6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
4F17

Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.

About Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.

Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. is a global innovation-driven pharmaceutical company in China, and is a core member enterprise of Fosun Pharma. Business covers the whole healthcare industry chain including pharmaceutical R&D, manufacturing, wholesale and distribution. Several production lines have passed FDA /EU site audits.  Key products include Human Insulins and GLP-1 products, EPO, and Heparin Sodium, OSD products such as Ticagrelor Tabs, Tofacitinib Tabs, Crizotinib Caps and Osimertinib Tabs.  Key APIs includes Insulins, Heparin Sodium, Venetoclax and Febuxostat

Certifications

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Contact info

Products from Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd. (21)